Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 183

1.

The Cardiothoracic Surgical Trials Network: Implications for clinical practice.

O'Gara PT, Sundt TM, Acker MA, David TE, Michler RE, Borger MA, Ailawadi G, Thourani VH, Gillinov AM, Damiano RJ, Mack MJ, Lee R, Rose EA, Gardner TJ, Miller MA, Weisel RD, Gelijns AC.

J Thorac Cardiovasc Surg. 2017 Dec;154(6):1938-1956. doi: 10.1016/j.jtcvs.2017.08.016. Epub 2017 Aug 24. No abstract available.

PMID:
29132888
2.

Prognostic Implications of Changes in Albumin Following Left Ventricular Assist Device Implantation in Patients With Severe Heart Failure.

Gopal DJ, Hanff TC, Mazurek JA, Grandin WE, Howard J, Forde-McLean R, Wald J, King K, Acker MA, Goldberg LR, Jessup M, Atluri P, Margulies KB, Rame EJ, Birati EY.

Am J Cardiol. 2017 Dec 1;120(11):2003-2007. doi: 10.1016/j.amjcard.2017.08.005. Epub 2017 Aug 30.

PMID:
28947307
3.

Clinical and In Vitro Evidence That Subclinical Hemolysis Contributes to LVAD Thrombosis.

Bartoli CR, Zhang D, Kang J, Hennessy-Strahs S, Restle D, Howard J, Redline G, Bermudez C, Atluri P, Acker MA.

Ann Thorac Surg. 2018 Mar;105(3):807-814. doi: 10.1016/j.athoracsur.2017.05.060. Epub 2017 Sep 21.

PMID:
28942075
4.

Different Clinical Course and Complications in Interagency Registry for Mechanically Assisted Circulatory Support 1 Patients Managed With or Without Extracorporeal Membrane Oxygenation.

Han JJ, Chung J, Chen CW, Gaffey AC, Sotolongo A, Justice C, Ameer AE, Rame JE, Bermudez C, Acker MA, Atluri P.

ASAIO J. 2017 Sep 21. doi: 10.1097/MAT.0000000000000674. [Epub ahead of print]

PMID:
28938306
5.

Effect of Cerebral Embolic Protection Devices on CNS Infarction in Surgical Aortic Valve Replacement: A Randomized Clinical Trial.

Mack MJ, Acker MA, Gelijns AC, Overbey JR, Parides MK, Browndyke JN, Groh MA, Moskowitz AJ, Jeffries NO, Ailawadi G, Thourani VH, Moquete EG, Iribarne A, Voisine P, Perrault LP, Bowdish ME, Bilello M, Davatzikos C, Mangusan RF, Winkle RA, Smith PK, Michler RE, Miller MA, O'Sullivan KL, Taddei-Peters WC, Rose EA, Weisel RD, Furie KL, Bagiella E, Moy CS, O'Gara PT, Messé SR; Cardiothoracic Surgical Trials Network (CTSN).

JAMA. 2017 Aug 8;318(6):536-547. doi: 10.1001/jama.2017.9479.

PMID:
28787505
6.

Improved Approach With Subcostal Exchange of the HeartMate II Left Ventricular Assist Device: Difference in On and Off Pump?

Gaffey AC, Chen CW, Chung JJ, Phillips E, Wald J, Williams ML, Low DW, Acker MA, Atluri P.

Ann Thorac Surg. 2017 Nov;104(5):1540-1546. doi: 10.1016/j.athoracsur.2017.04.047. Epub 2017 Jul 29.

PMID:
28760470
7.

Continuous-Flow LVAD Support Causes a Distinct Form of Intestinal Angiodysplasia.

Kang J, Hennessy-Strahs S, Kwiatkowski P, Bermudez CA, Acker MA, Atluri P, McConnell PI, Bartoli CR.

Circ Res. 2017 Sep 29;121(8):963-969. doi: 10.1161/CIRCRESAHA.117.310848. Epub 2017 Jul 20.

PMID:
28729354
8.

Extended distance cardiac allograft can successfully be utilized without impacting long-term survival.

Gaffey AC, Chen CW, Chung JJ, Han J, Owens A, Acker MA, Atluri P.

J Heart Lung Transplant. 2017 Sep;36(9):968-972. doi: 10.1016/j.healun.2017.04.002. Epub 2017 Apr 15.

PMID:
28457697
9.

2016 update to The American Association for Thoracic Surgery (AATS) consensus guidelines: Ischemic mitral valve regurgitation.

AATS Ischemic Mitral Regurgitation Consensus Guidelines Writing Committee, Kron IL, LaPar DJ, Acker MA, Adams DH, Ailawadi G, Bolling SF, Hung JW, Lim DS, Mack MJ, O'Gara PT, Parides MK, Puskas JD.

J Thorac Cardiovasc Surg. 2017 May;153(5):e97-e114. doi: 10.1016/j.jtcvs.2017.01.031. Epub 2017 Feb 7. No abstract available.

PMID:
28411753
10.

Long-term outcome of surgical cryoablation for refractory ventricular tachycardia in patients with non-ischemic cardiomyopathy.

Liang JJ, Betensky BP, Muser D, Zado ES, Anter E, Desai ND, Callans DJ, Deo R, Frankel DS, Hutchinson MD, Lin D, Riley MP, Schaller RD, Supple GE, Santangeli P, Acker MA, Bavaria JE, Szeto WY, Vallabhajosyula P, Marchlinski FE, Dixit S.

Europace. 2017 Apr 10. doi: 10.1093/europace/eux029. [Epub ahead of print]

PMID:
28402404
11.

Non-cardiac surgery in patients with continuous-flow left ventricular assist devices: a single institutional experience.

Chen CW, Dumon KR, Shaked O, Acker MA, Atluri P, Dempsey DT.

J Investig Med. 2017 Jun;65(5):912-918. doi: 10.1136/jim-2016-000297. Epub 2017 Mar 24.

PMID:
28341625
12.

Low ejection fraction in donor hearts is not directly associated with increased recipient mortality.

Chen CW, Sprys MH, Gaffey AC, Chung JJ, Margulies KB, Acker MA, Atluri P.

J Heart Lung Transplant. 2017 Jun;36(6):611-615. doi: 10.1016/j.healun.2017.02.001. Epub 2017 Feb 4.

PMID:
28314504
13.

2016 update to The American Association for Thoracic Surgery consensus guidelines: Ischemic mitral valve regurgitation.

American Association For Thoracic Surgery Ischemic Mitral Regurgitation Consensus Guidelines Writing Committee, Kron IL, LaPar DJ, Acker MA, Adams DH, Ailawadi G, Bolling SF, Hung JW, Lim DS, Mack MJ, O'Gara PT, Parides MK, Puskas JD.

J Thorac Cardiovasc Surg. 2017 May;153(5):1076-1079. doi: 10.1016/j.jtcvs.2016.11.068. Epub 2017 Jan 17. No abstract available.

PMID:
28190606
14.

Bridge with a left ventricular assist device to a simultaneous heart and kidney transplant: Review of the United Network for Organ Sharing database.

Gaffey AC, Chen CW, Chung J, Grandin EW, Porrett PM, Acker MA, Atluri P.

J Card Surg. 2017 Mar;32(3):209-214. doi: 10.1111/jocs.13105. Epub 2017 Feb 8.

PMID:
28176387
15.

Achieving safe and expeditious distal limb perfusion in femoral venoarterial extracorporeal life support.

Arnaoutakis GJ, Acker MA, Vallabhajosyula P.

J Thorac Cardiovasc Surg. 2017 Feb;153(2):371-372. doi: 10.1016/j.jtcvs.2016.10.001. No abstract available.

PMID:
28104195
16.

Higher Body Mass Index Increases Risk of HeartMate II Pump Thrombosis But Does Not Adversely Affect Long-Term Survival.

Han JJ, Sooppan R, Johnson AP, Chen CW, Gaffey AC, Phillips EC, Howard J, Rame JE, Acker MA, Atluri P.

Circ J. 2017 Jan 25;81(2):213-219. doi: 10.1253/circj.CJ-16-0942. Epub 2016 Dec 22.

17.

The NHLBI REVIVE-IT study: Understanding its discontinuation in the context of current left ventricular assist device therapy.

Pagani FD, Aaronson KD, Kormos R, Mann DL, Spino C, Jeffries N, Taddei-Peters WC, Mancini DM, McNamara DM, Grady KL, Gorcsan J 3rd, Petrucci R, Anderson AS, Glick HA, Acker MA, Eduardo Rame J, Goldstein DJ, Pamboukian SV, Miller MA, Timothy Baldwin J; REVIVE-IT Investigators.

J Heart Lung Transplant. 2016 Nov;35(11):1277-1283. doi: 10.1016/j.healun.2016.09.002. Epub 2016 Oct 6.

PMID:
27836022
18.

Valve Selection in End-Stage Renal Disease: Should It Always Be Biological?

Williams ML, Bavaria JE, Acker MA, Desai ND, Vallabhajosyula P, Hargrove WC, Atluri P, Szeto WY.

Ann Thorac Surg. 2016 Nov;102(5):1531-1535. doi: 10.1016/j.athoracsur.2016.04.092. Epub 2016 Aug 17.

PMID:
27544289
19.

The value of preoperative 3-dimensional over 2-dimensional valve analysis in predicting recurrent ischemic mitral regurgitation after mitral annuloplasty.

Wijdh-den Hamer IJ, Bouma W, Lai EK, Levack MM, Shang EK, Pouch AM, Eperjesi TJ, Plappert TJ, Yushkevich PA, Hung J, Mariani MA, Khabbaz KR, Gleason TG, Mahmood F, Acker MA, Woo YJ, Cheung AT, Gillespie MJ, Jackson BM, Gorman JH 3rd, Gorman RC.

J Thorac Cardiovasc Surg. 2016 Sep;152(3):847-59. doi: 10.1016/j.jtcvs.2016.06.040. Epub 2016 Jun 29.

20.

Pathogenesis and Risk Factors for Cerebral Infarct After Surgical Aortic Valve Replacement.

Massaro A, Messé SR, Acker MA, Kasner SE, Torres J, Fanning M, Giovannetti T, Ratcliffe SJ, Bilello M, Szeto WY, Bavaria JE, Mohler ER 3rd, Floyd TF; Determining Neurologic Outcomes From Valve Operations (DeNOVO) Investigators.

Stroke. 2016 Aug;47(8):2130-2. doi: 10.1161/STROKEAHA.116.013970. Epub 2016 Jul 5.

21.

Unconventional Volume-Outcome Associations in Adult Extracorporeal Membrane Oxygenation in the United States.

McCarthy FH, McDermott KM, Spragan D, Hoedt A, Kini V, Atluri P, Gaffey A, Szeto WY, Acker MA, Desai ND.

Ann Thorac Surg. 2016 Aug;102(2):489-95. doi: 10.1016/j.athoracsur.2016.02.009. Epub 2016 Apr 26.

PMID:
27130248
22.

Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.

Michler RE, Smith PK, Parides MK, Ailawadi G, Thourani V, Moskowitz AJ, Acker MA, Hung JW, Chang HL, Perrault LP, Gillinov AM, Argenziano M, Bagiella E, Overbey JR, Moquete EG, Gupta LN, Miller MA, Taddei-Peters WC, Jeffries N, Weisel RD, Rose EA, Gammie JS, DeRose JJ Jr, Puskas JD, Dagenais F, Burks SG, El-Hamamsy I, Milano CA, Atluri P, Voisine P, O'Gara PT, Gelijns AC; CTSN.

N Engl J Med. 2016 May 19;374(20):1932-41. doi: 10.1056/NEJMoa1602003. Epub 2016 Apr 3.

23.

2015 The American Association for Thoracic Surgery Consensus Guidelines: Ischemic mitral valve regurgitation.

American Association for Thoracic Surgery Ischemic Mitral Regurgitation Consensus Guidelines Writing Committee, Kron IL, Acker MA, Adams DH, Ailawadi G, Bolling SF, Hung JW, Lim DS, LaPar DJ, Mack MJ, O'Gara PT, Parides MK, Puskas JD.

J Thorac Cardiovasc Surg. 2016 Apr;151(4):940-56. doi: 10.1016/j.jtcvs.2015.08.127. Epub 2016 Feb 4. Review. No abstract available.

PMID:
26995621
24.

Reduced continuous-flow left ventricular assist device speed does not decrease von Willebrand factor degradation.

Kang J, Zhang DM, Restle DJ, Kallel F, Acker MA, Atluri P, Bartoli CR.

J Thorac Cardiovasc Surg. 2016 Jun;151(6):1747-1754.e1. doi: 10.1016/j.jtcvs.2016.01.031. Epub 2016 Jan 30.

PMID:
26971377
25.

Comparison of Causes of Death After Heart Transplantation in Patients With Left Ventricular Ejection Fractions ≤35% Versus >35.

Birati EY, Mathelier H, Molina M, Hanff TC, Mazurek JA, Atluri P, Acker MA, Rame JE, Margulies KB, Goldberg LR, Jessup M.

Am J Cardiol. 2016 Apr 15;117(8):1322-6. doi: 10.1016/j.amjcard.2016.01.028. Epub 2016 Jan 28.

PMID:
26899490
26.

Transplantation of "high-risk" donor hearts: Implications for infection.

Gaffey AC, Doll SL, Thomasson AM, Venkataraman C, Chen CW, Goldberg LR, Blumberg EA, Acker MA, Stone F, Atluri P.

J Thorac Cardiovasc Surg. 2016 Jul;152(1):213-20. doi: 10.1016/j.jtcvs.2015.12.062. Epub 2016 Jan 22.

PMID:
26898978
27.

History and Current Status of Cardiovascular Surgery at the University of Pennsylvania.

Acker MA, Bavaria JE, Barker CF.

Semin Thorac Cardiovasc Surg. 2015 Winter;27(4):370-3. doi: 10.1053/j.semtcvs.2015.10.012.

PMID:
26811043
28.

Dealing with surgical left ventricular assist device complications.

Kilic A, Acker MA, Atluri P.

J Thorac Dis. 2015 Dec;7(12):2158-64. doi: 10.3978/j.issn.2072-1439.2015.10.64. Review.

29.

Transplantation of Center for Disease Control "High-Risk" Donor Hearts Does Not Adversely Impact Long-Term Outcomes in Adults.

Gaffey AC, Cucchiara AJ, Goldberg LR, Blumberg EA, Acker MA, Atluri P.

J Card Fail. 2016 May;22(5):376-82. doi: 10.1016/j.cardfail.2016.01.008. Epub 2016 Jan 15.

PMID:
26779827
30.

HeartMate II Left Ventricular Assist Device Geometry on Chest Radiograph Does Not Correlate with Risk of Pump Thrombosis.

Han JJ, Gaffey AC, Sooppan R, Hung G, Venkataraman C, Phillips E, Howard J, McLean R, Acker MA, Atluri P.

ASAIO J. 2016 Mar-Apr;62(2):128-32. doi: 10.1097/MAT.0000000000000326.

PMID:
26720737
31.

Randomized Comparison of Percutaneous Repair and Surgery for Mitral Regurgitation: 5-Year Results of EVEREST II.

Feldman T, Kar S, Elmariah S, Smart SC, Trento A, Siegel RJ, Apruzzese P, Fail P, Rinaldi MJ, Smalling RW, Hermiller JB, Heimansohn D, Gray WA, Grayburn PA, Mack MJ, Lim DS, Ailawadi G, Herrmann HC, Acker MA, Silvestry FE, Foster E, Wang A, Glower DD, Mauri L; EVEREST II Investigators.

J Am Coll Cardiol. 2015 Dec 29;66(25):2844-2854. doi: 10.1016/j.jacc.2015.10.018.

32.

Preoperative Three-Dimensional Valve Analysis Predicts Recurrent Ischemic Mitral Regurgitation After Mitral Annuloplasty.

Bouma W, Lai EK, Levack MM, Shang EK, Pouch AM, Eperjesi TJ, Plappert TJ, Yushkevich PA, Mariani MA, Khabbaz KR, Gleason TG, Mahmood F, Acker MA, Woo YJ, Cheung AT, Jackson BM, Gorman JH 3rd, Gorman RC.

Ann Thorac Surg. 2016 Feb;101(2):567-75; discussion 575. doi: 10.1016/j.athoracsur.2015.09.076. Epub 2015 Dec 12.

33.

Trends in U.S. Extracorporeal Membrane Oxygenation Use and Outcomes: 2002-2012.

McCarthy FH, McDermott KM, Kini V, Gutsche JT, Wald JW, Xie D, Szeto WY, Bermudez CA, Atluri P, Acker MA, Desai ND.

Semin Thorac Cardiovasc Surg. 2015 Summer;27(2):81-8. doi: 10.1053/j.semtcvs.2015.07.005. Epub 2015 Jul 22.

34.

Pump thrombosis in the Thoratec HeartMate II device: An update analysis of the INTERMACS Registry.

Kirklin JK, Naftel DC, Pagani FD, Kormos RL, Myers S, Acker MA, Rogers J, Slaughter MS, Stevenson LW.

J Heart Lung Transplant. 2015 Dec;34(12):1515-26. doi: 10.1016/j.healun.2015.10.024.

PMID:
26681121
35.

Severe ischemic mitral regurgitation: Repair or replace?

Acker MA, Dagenais F, Goldstein D, Kron IL, Perrault LP.

J Thorac Cardiovasc Surg. 2015 Dec;150(6):1425-7. doi: 10.1016/j.jtcvs.2015.09.018. Epub 2015 Sep 18. No abstract available.

36.

Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation.

Goldstein D, Moskowitz AJ, Gelijns AC, Ailawadi G, Parides MK, Perrault LP, Hung JW, Voisine P, Dagenais F, Gillinov AM, Thourani V, Argenziano M, Gammie JS, Mack M, Demers P, Atluri P, Rose EA, O'Sullivan K, Williams DL, Bagiella E, Michler RE, Weisel RD, Miller MA, Geller NL, Taddei-Peters WC, Smith PK, Moquete E, Overbey JR, Kron IL, O'Gara PT, Acker MA; CTSN.

N Engl J Med. 2016 Jan 28;374(4):344-53. doi: 10.1056/NEJMoa1512913. Epub 2015 Nov 9.

37.

Repair or replace for severe ischemic mitral regurgitation: prospective randomized multicenter data.

LaPar DJ, Acker MA, Gelijns AC, Kron IL.

Ann Cardiothorac Surg. 2015 Sep;4(5):411-6. doi: 10.3978/j.issn.2225-319X.2015.04.11. Review.

38.

Inhibition of ADAMTS-13 by Doxycycline Reduces von Willebrand Factor Degradation During Supraphysiological Shear Stress: Therapeutic Implications for Left Ventricular Assist Device-Associated Bleeding.

Bartoli CR, Kang J, Restle DJ, Zhang DM, Shabahang C, Acker MA, Atluri P.

JACC Heart Fail. 2015 Nov;3(11):860-9. doi: 10.1016/j.jchf.2015.06.016. Epub 2015 Oct 7.

PMID:
26454844
39.

Minimally invasive mitral valve surgery is associated with equivalent cost and shorter hospital stay when compared with traditional sternotomy.

Atluri P, Stetson RL, Hung G, Gaffey AC, Szeto WY, Acker MA, Hargrove WC.

J Thorac Cardiovasc Surg. 2016 Feb;151(2):385-8. doi: 10.1016/j.jtcvs.2015.08.106. Epub 2015 Sep 5.

40.

Increasing Frequency of Left Ventricular Assist Device Exchanges in the United States.

McCarthy FH, Kobrin D, Rame JE, Groeneveld PW, McDermott KM, Atluri P, Acker MA, Desai ND.

Ann Thorac Surg. 2015 Nov;100(5):1660-4; discussion 1665. doi: 10.1016/j.athoracsur.2015.04.072. Epub 2015 Jul 21.

PMID:
26209488
41.

We need a better way to repair ischemic mitral regurgitation.

Kron IL, Perrault LP, Acker MA.

J Thorac Cardiovasc Surg. 2015 Aug;150(2):428. doi: 10.1016/j.jtcvs.2015.04.002. No abstract available.

42.

Prior Sternotomy and Ventricular Assist Device Implantation Do Not Adversely Impact Survival or Allograft Function After Heart Transplantation.

Gaffey AC, Phillips EC, Howard J, Hung G, Han J, Emery R, Goldberg L, Acker MA, Woo YJ, Atluri P.

Ann Thorac Surg. 2015 Aug;100(2):542-9. doi: 10.1016/j.athoracsur.2015.02.093. Epub 2015 Jun 9.

PMID:
26070597
43.

Surgical ablation of atrial fibrillation during mitral-valve surgery.

Gillinov AM, Gelijns AC, Parides MK, DeRose JJ Jr, Moskowitz AJ, Voisine P, Ailawadi G, Bouchard D, Smith PK, Mack MJ, Acker MA, Mullen JC, Rose EA, Chang HL, Puskas JD, Couderc JP, Gardner TJ, Varghese R, Horvath KA, Bolling SF, Michler RE, Geller NL, Ascheim DD, Miller MA, Bagiella E, Moquete EG, Williams P, Taddei-Peters WC, O'Gara PT, Blackstone EH, Argenziano M; CTSN Investigators.

N Engl J Med. 2015 Apr 9;372(15):1399-409. doi: 10.1056/NEJMoa1500528. Epub 2015 Mar 16.

44.

Preclinical Models for Translational Investigations of Left Ventricular Assist Device-Associated von Willebrand Factor Degradation.

Restle DJ, Zhang DM, Hung G, Howard JL, Kallel F, Acker MA, Atluri P, Bartoli CR.

Artif Organs. 2015 Jul;39(7):569-75. doi: 10.1111/aor.12428. Epub 2015 Mar 21.

PMID:
25810063
45.

Costs associated with health care-associated infections in cardiac surgery.

Greco G, Shi W, Michler RE, Meltzer DO, Ailawadi G, Hohmann SF, Thourani VH, Argenziano M, Alexander JH, Sankovic K, Gupta L, Blackstone EH, Acker MA, Russo MJ, Lee A, Burks SG, Gelijns AC, Bagiella E, Moskowitz AJ, Gardner TJ.

J Am Coll Cardiol. 2015 Jan 6;65(1):15-23. doi: 10.1016/j.jacc.2014.09.079.

46.

Predicting recurrent mitral regurgitation after mitral valve repair for severe ischemic mitral regurgitation.

Kron IL, Hung J, Overbey JR, Bouchard D, Gelijns AC, Moskowitz AJ, Voisine P, O'Gara PT, Argenziano M, Michler RE, Gillinov M, Puskas JD, Gammie JS, Mack MJ, Smith PK, Sai-Sudhakar C, Gardner TJ, Ailawadi G, Zeng X, O'Sullivan K, Parides MK, Swayze R, Thourani V, Rose EA, Perrault LP, Acker MA; CTSN Investigators.

J Thorac Cardiovasc Surg. 2015 Mar;149(3):752-61.e1. doi: 10.1016/j.jtcvs.2014.10.120. Epub 2014 Nov 6.

47.

Pathologic von Willebrand factor degradation with a left ventricular assist device occurs via two distinct mechanisms: mechanical demolition and enzymatic cleavage.

Bartoli CR, Restle DJ, Zhang DM, Acker MA, Atluri P.

J Thorac Cardiovasc Surg. 2015 Jan;149(1):281-9. doi: 10.1016/j.jtcvs.2014.09.031. Epub 2014 Sep 18.

48.

Surgical treatment of moderate ischemic mitral regurgitation.

Smith PK, Puskas JD, Ascheim DD, Voisine P, Gelijns AC, Moskowitz AJ, Hung JW, Parides MK, Ailawadi G, Perrault LP, Acker MA, Argenziano M, Thourani V, Gammie JS, Miller MA, Pagé P, Overbey JR, Bagiella E, Dagenais F, Blackstone EH, Kron IL, Goldstein DJ, Rose EA, Moquete EG, Jeffries N, Gardner TJ, O'Gara PT, Alexander JH, Michler RE; Cardiothoracic Surgical Trials Network Investigators.

N Engl J Med. 2014 Dec 4;371(23):2178-88. doi: 10.1056/NEJMoa1410490. Epub 2014 Nov 18.

49.

Complex wound management in ventricular assist device (VAD) patients: the role of aggressive debridement and vascularized soft tissue coverage.

Nelson JA, Shaked O, Fischer JP, Mirzabeigi MN, Jandali S, Kovach SJ 3rd, Low DW, Acker MA, Kanchwala SK.

Ann Plast Surg. 2014 Dec;73 Suppl 2:S165-70. doi: 10.1097/SAP.0000000000000228.

PMID:
25393384
50.

Readmissions after cardiac surgery: experience of the National Institutes of Health/Canadian Institutes of Health research cardiothoracic surgical trials network.

Iribarne A, Chang H, Alexander JH, Gillinov AM, Moquete E, Puskas JD, Bagiella E, Acker MA, Mayer ML, Ferguson TB, Burks S, Perrault LP, Welsh S, Johnston KC, Murphy M, DeRose JJ, Neill A, Dobrev E, Baio KT, Taddei-Peters W, Moskowitz AJ, O'Gara PT.

Ann Thorac Surg. 2014 Oct;98(4):1274-80. doi: 10.1016/j.athoracsur.2014.06.059. Epub 2014 Aug 28.

Supplemental Content

Loading ...
Support Center